Sinopharm Group Co Ltd - Free Cash Flow To Equity
Sinopharm Group Co Ltd's Fiscal Year is From January To December - All Figures are in CNY, Billions.
The item "Free-Cash-Flow-To-Equity" stands at -35.86 Billion Chinese Yuans for the trailing twelve months (TTM) period ending 03/31/2024.'
Regarding the One-Year-Change of the series, the current value constitutes an decrease of -19.91 Billion Chinese Yuans compared to the value the year prior.
The 1 year change is -19.91 Billion Chinese Yuans.
The 3 year change is -14.47 Billion Chinese Yuans.
The 5 year change is -57.05 Billion Chinese Yuans.
The 10 year change is -15.64 Billion Chinese Yuans.
The Serie's change in Chinese Yuans from it's minimum value, on 12/31/2023, to it's latest available value, on 03/31/2024, is +25.44 Billion.
The Serie's change in Chinese Yuans from it's maximum value, on 03/31/2019, to it's latest available value, on 03/31/2024, is -57.05 Billion.
Free Cash Flow To Equity for Related Companies:
| Logo | Name | Market Cap (USD) |
|---|---|---|
 | McKesson Corporation - Free Cash Flow To Equity | 100,579,704,832.00 |
 | Cencora Inc. - Free Cash Flow To Equity | 65,891,811,328.00 |
 | Cardinal Health Inc - Free Cash Flow To Equity | 47,241,023,488.00 |
 | Pop Mart International Group Ltd - Free Cash Flow To Equity | 32,494,046,097.69 |
 | BANDAI NAMCO Holdings Inc. - Free Cash Flow To Equity | 17,589,959,037.23 |